Find a story

Search Spins

Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.

5 results for “life sciences”

SPIN Processed News Frame: The Cushion

Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences (Financial Times)

Dassault Systèmes is negotiating a ~$2B acquisition of ArisGlobal, a drug trial software company owned by Nordic Capital, to accelerate its strategic expansion into the life sciences sector.

Spin 50% Claim Present in Source AI Risk Moderate
Techmeme

Jul 17, 2026

SPIN Processed News Frame: The Hype

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

An unconfirmed report claims OpenAI researcher Miles Wang is in early-stage talks to launch an AI drug discovery startup with a $2B valuation, reflecting investor enthusiasm for AI-driven biotech innovation.

Spin 75% Needs Evidence AI Risk High
TechCrunch

Jul 15, 2026

SPIN Processed Press Release Frame: The Cushion

Momentum Life Sciences Announces Strategic Growth Investment from Parthenon Capital - Business Wire

Momentum Life Sciences, a life sciences company, announced a strategic growth investment from private equity firm Parthenon Capital, signaling expansion intent but with no disclosed financial terms, use of funds, or operational impact.

Spin 75% Claim Present in Source
Business Wire Financial Services via Google News

Published Jul 1, 2026 · Analyzed Jul 7, 2026

SPIN Processed Company Announcement Frame: The Hype

NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery

NVIDIA launched a new AI toolkit called BioNeMo Agent Toolkit to equip AI agents with life sciences–specific capabilities for drug discovery and research.

Spin 88% Needs Evidence AI Risk High
NVIDIA Newsroom

Published Jun 23, 2026 · Analyzed Jul 4, 2026

SPIN Processed Company Announcement Frame: The Hype

Opening new paths in aging research

Calico Life Sciences deployed Google DeepMind's Co-Scientist AI tool to synthesize fragmented aging research and propose novel hypotheses.

Spin 82% Needs Evidence AI Risk High
Google DeepMind Blog

Published May 16, 2026 · Analyzed Jul 3, 2026